Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

DPAG is the host Department for the annual Oxosome meetings, which bring together researchers from across Oxford with an interest in cell communication involving exosomes and other extracellular vesicles.  

The third annual meeting of Oxosome: the extracellular vesicle group organised by Deborah Goberdhan (DPAG), Dave Carter (Oxford Brookes), Eduard Willms (DPhil student, Wood lab, DPAG) and Maria Laura Tognoli (DPhil student, O’Neill lab, Dept of Oncology) was held on the afternoon of Thursday 1 November 2018 in the Sherrington Large Lecture Theatre with around 120 people participating.  

The talks showcased the quality and breadth of local research on extracellular vesicles, with speakers from a wide range of departments:  DPAG, Sir William Dunn School of Pathology, Kennedy Institute of Rheumatology, Dept of Oncology, Radcliffe Dept of Medicine, Nuffield Dept of Clinical Neurosciences and Biological and Medical Sciences at Oxford Brookes.  The talks spanned all the way from fundamental studies of vesicle biology to clinical disorders, including myocardial infarction, cancer, and neurodegenerative disease.

There was plenty of opportunity for interaction and discussion of collaborative work during the coffee break and subsequent wine reception.

Generous sponsorship from DPAG, IZON Science Ltd, EVOX Therapeutics Ltd, NanoView Bios, ONI Ltd and Analytik Ltd enabled the meeting to be held free of charge.

Similar stories

Iron deficiency anaemia in early pregnancy increases risk of heart defects, suggests new research

In animal models, iron deficient mothers have a greatly increased risk of having offspring with congenital heart disease (CHD). The risk of CHD can be greatly reduced if the mother is given iron supplements very early in pregnancy. Additionally, embryos from a mouse model of Down Syndrome were particularly vulnerable to the effects of maternal iron deficiency, leading to a higher risk of developing severe heart defects.

New target to develop immunosuppressants

A new study from the Parekh Group has resolved a long-standing question in our understanding of intracellular Ca2+ signalling, namely how a specific type of Ca2+ channel is uniquely able to signal to the nucleus to regulate gene expression. By unravelling this mechanism, researchers have identified a new approach for developing immunosuppressant drugs.

How the kidney contributes to healthy iron levels and disease

A new study from the Lakhal-Littleton Group has addressed a long-standing gap in our understanding of systemic iron homeostasis. It provides the first formal demonstration that the hormone hepcidin controls iron reabsorption in the kidney, in a manner that impacts the body’s iron levels, under normal physiological conditions. It also demonstrates for the first time how this mechanism becomes critically important in the development of iron disorders.

New research to radically alter our understanding of synaptic development

A new study from the Molnár group on the role of regulated synaptic vesicular release in specialised synapse formation has made it to the cover of Cerebral Cortex.

Being "in the zone": how waking activity controls sleep need

A new study from the Vyazovskiy group suggests that how and where we spend our time while awake impacts how much we need to sleep - it does not only depend on how long we are awake.